Job title: Associate Vice President, Clinical Development
Star Seyedkazemi is the Associate Vice President in Clinical Development at Allergan, primarily responsible for global clinical development of therapeutic agents and combinations for nonalcoholic steatohepatitis. Prior to joining Allergan as part of its acquisition of Tobira Therapeutics, Star served as the medical lead for the phase 2 and 3 trials to evaluate the efficacy and safety of cenicriviroc, a novel CCR2/5 antagonist, for the treatment of liver fibrosis associated with NASH.
Star received her Doctor of Pharmacy degree from Nova Southeastern University and completed a HIV specialty residency. Her career includes pharmaceutical industry experience in global clinical development and medical affairs in liver and infectious diseases, preceded by clinical care and research.